Abstract

Introduction: Emergent technologies, i.e., monopolar capacitive coupled Radiofrequency (mcRF) and Platelet Rich Plasma (PRP) are now available to treat conditions characterized by a failed Wound Healing Response. Both mcRF and PRP positively influence the chemical/cellular inflammatory cascade to promote healing. mcRF application results in temperature elevation at the targeted structure up to 50℃ stimulating heat shock proteins, thus inciting the Wound Healing Response. Ultrasound-guided PRP injections results in an inflammatory/reparative reaction through cytokinin release. Methods: Sixty-eight patients who have failed previous conservative treatment for tendinopathies and chronic ligament conditions of the elbow, hip, knee and ankle/foot, were treated either with mcRF or PRP. Treatments were delivered directly by the investigator, and patients were followed prospectively for an average of 19.7 months (range 15 to 24 months). Results: Average age for the mcRF cohort was 53 years (range 17 to 88). Average age for the PRP group was 58 (range 19 to 90). The male to female ratio for both groups was 1/1. 33 of 42 patients treated with mcRF experienced marked improvement (78%), while in the PRP group 19 of 26 patients experienced marked improvement (73%) as self-assessed by study subjects. Discussion/Conclusion: Results of this study are in agreement with reports on the use of both technologies; however, this is the first time that a side-by-side comparison is established. PRP and mcRF represent a new approach to musculoskeletal pathology; both modalities aim at inducing a biological response and are considered at the frontier of regenerative therapeutics. The high safety profile suggests that these, non-invasive (mcRF) and minimally invasive (PRP), office-based alternatives for the management of musculoskeletal conditions are valuable tools and should be used in accordance with a clear understanding of the underlying pathology.

Highlights

  • Emergent technologies, i.e., monopolar capacitive coupled Radiofrequency and Platelet Rich Plasma (PRP) are available to treat conditions characterized by a failed Wound Healing Response

  • PRP and monopolar capacitive coupled Radiofrequency (mcRF) represent a new approach to musculoskeletal pathology; both modalities aim at inducing a biological response and are considered at the frontier of regenerative therapeutics

  • The high safety profile suggests that these, non-invasive and minimally invasive (PRP), office-based alternatives for the management of musculoskeletal conditions are valuable tools and should be used in accordance with a clear understanding of the underlying pathology

Read more

Summary

Introduction

I.e., monopolar capacitive coupled Radiofrequency (mcRF) and Platelet Rich Plasma (PRP) are available to treat conditions characterized by a failed Wound Healing Response. I.e., monopolar capacitive coupled Radiofrequency (mcRF) (RelēF Technology, Alpha Orthopaedics, Inc. Oakland, CA) and Platelet Rich Plasma (PRP) are available to treat conditions characterized by a failed Wound Healing Response. Outcomes of current non-invasive treatment modalities are similar to a “wait and see” approach [2,3,4] indicating of a low level of effectiveness The cost of these pathologies in terms of lost productivity and health care is significant with a clear association with work-related activities with an annual incidence of Openly accessible at http://www.scirp.org/journal/health/

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call